Login / Signup

Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma.

Shu-Yein HoPo-Hong LiuChia-Yang HsuCheng-Yuan HsiaChien-Wei SuYi-Jhen HeYun-Hsuan LeeYi-Hsiang HuangMing-Chih HouTeh-Ia Huo
Published in: Scientific reports (2018)
The Ishak scoring system has been used to stage liver fibrosis. Ten noninvasive liver reserve models were proposed to assess the severity of liver fibrosis, but their performance in hepatocellular carcinoma (HCC) is unknown. We aimed to evaluate the correlation between these models and severity of fibrosis in patients with HCC. A total 464 patients with HCC undergoing surgical resection were retrospectively analyzed. Multivariate logistic regression analysis was performed to determine independent factors associated with advanced fibrosis (Ishak score 4 or higher). There were no significant correlations between all noninvasive models and severity of fibrosis in HCC (p for trend all >0.1). In subgroup analysis, cirrhosis discriminant index (CDS) and Lok's index in hepatitis B-, and fibrosis index based on 4 factors (FIB-4), CDS and Lok's index in hepatitis C-associated HCC, best correlated with the severity of liver fibrosis. Low platelet count, prolonged prothrombin time, hepatitis C and multiple tumors were independently associated with advanced fibrosis. Among the 10 models, CDS was the best model to predict cirrhosis. Currently used noninvasive liver reserve models do not well correlate with severity of histological fibrosis in HCC. New noninvasive models are required to improve the predictive accuracy of liver fibrosis in HCC.
Keyphrases
  • liver fibrosis
  • quantum dots
  • randomized controlled trial
  • clinical trial
  • study protocol
  • peripheral blood